Insulet Corporation Shares Up 7% on FDA Omnipod 5 Approval
<p><a href='https://financialmodelingprep.com/financial-summary/PODD'>Insulet Corporation (NASDAQ:PODD) </a>shares closed 7.55% higher on Monday following the FDA approval of the company's Omnipod 5.</p>
<p>Analysts at Oppenheimer upgraded the company to outperform from perform following the approval, noting that they also see upside opportunities over the medium term on potential O5 international expansion. </p>
<p>The company’s management hasn't yet communicated timelines, but the analysts assume the company would look to target international O5 expansion over the medium term.</p>

NASDAQ:PODD